Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Quick Stats
Jan 30, 202652.2
AI Score
HOLD1.05
Volume Ratio
Feb 26, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
ACLX Stock Summary
Last updated Jan 30, 2026
ACLX is currently trading at $68.31, positioned below its 200-day moving average of $71.6, suggesting bearish momentum. The stock has a 52-week range of $47.8601 to $94.07.
Technical Analysis: The 50-day moving average stands at $69.82, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 50.146, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.132, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ACLX at 52.2/100 with a HOLD recommendation.
ACLX (Arcellx, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.146 |
| CMF (20) | 0.132 |
| ROC (10) | -0.015 |
| ADX (14) | 20.519 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.177 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -62.187 |
| MFI (14) | 55.596 |
ACLX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ACLX Price vs Max Options Open Interest
ACLX Max Change In Options Open Interest
ACLX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACLX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACLX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACLX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Arcellx, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ACLX Moving Averages Analysis
ACLX (Arcellx, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 68.82 |
| 20 | 67.04 |
| 30 | 66.34 |
| 50 | 69.82 |
| 100 | 76.89 |
| 200 | 71.6 |
ACLX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.9 billion |
| Earnings/Share ($) | -3.93 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.0086 |
| EPS Estimate Next Year ($) | -3.388 |
| WallStreet Target Price ($) | 112.3529 |
| Most Recent Quarter |